Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Axitinib treatment turned a man's grey hair back to black.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Cetuximab can cause skin cysts after acne-like eruptions.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Chemotherapy and certain hair care practices can cause severe hair matting.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Erlotinib can cause hair loss as a side effect.